ADC Therapeutics SA (NYSE:ADCT)
ADC Therapeutics SA
NYSE:ADCT
P/B
Price to Book Value
The Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
= Market Cap
/ Book Value of Equity
Current P/B
ADCT
3.8
Median P/B
ADCT
9.2
Industry P/B
Biotechnology
2.2
P/B History
Statistics
Price to Book Value
Price to Book Value
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | 7.9 | 10.9 | 6.6 |
| Median | 7.7 | 9.2 | 6.3 |
| Min | 3.1 | N/A | N/A |
| Max | 12.9 | 25 | 25 |
History Chart
Price to Book Value
Price to Book Value
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
P/B Across Competitors
ADCT Competitors
ADC Therapeutics SA Competitors
ADC Therapeutics SA Competitors
Relative Valuation Report
View full relative valuation report for ADC Therapeutics SA, which takes into account all ADCT`s valuation multiples.
